Bank of Montreal’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-300
Closed -$30.6K 3846
2025
Q4
$30.6K Buy
+300
New +$26.8K ﹤0.01% 3285

Other funds holding GH

Bank of Montreal's GH Position: Q1 2026 in Review

Bank of Montreal increased its Guardant Health (GH) stake by 212% in Q1 2026, buying an estimated $1.84M and bringing the position to 26,915 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

Bank of Montreal first reported a position in GH in Q2 2019 and has held it in 24 quarters since. The position peaked at $14.9M in Q2 2021. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Bank of Montreal held 26,915 shares of Guardant Health worth $2.49M as of Q1 2026.
  • Bank of Montreal bought 18,283 Guardant Health shares in Q1 2026, an estimated $1.84M.
  • Guardant Health made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #1570 holding.
  • Bank of Montreal first reported a position in Guardant Health in Q2 2019 and has held it in 24 quarters since.
  • Bank of Montreal's Guardant Health position peaked at $14.9M in Q2 2021.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.